Your SlideShare is downloading. ×
2012 Market Research Report on China Synthesis Polypeptide Drug Industry
2012 Market Research Report on China Synthesis Polypeptide Drug Industry
2012 Market Research Report on China Synthesis Polypeptide Drug Industry
2012 Market Research Report on China Synthesis Polypeptide Drug Industry
2012 Market Research Report on China Synthesis Polypeptide Drug Industry
2012 Market Research Report on China Synthesis Polypeptide Drug Industry
2012 Market Research Report on China Synthesis Polypeptide Drug Industry
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

2012 Market Research Report on China Synthesis Polypeptide Drug Industry

385

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
385
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. 2012 Market Research Report on China Synthesis PolypeptideDrug IndustryReport Details:Published:August 2012No. of Pages: 152Price: Single User License – US$20002012 Market Research Report on China Synthesis Polypeptide Drug Industry was professionaland depth research report on China Synthesis Polypeptide Drug industry. The report firstlyintroduced Synthesis Polypeptide Drug basic information included Synthesis Polypeptide Drugdefinition classification application industry chain structure industry overview; international marketanalysis, China domestic market analysis, Macroeconomic environment and economic situationanalysis and influence, Synthesis Polypeptide Drug industry policy and plan, SynthesisPolypeptide Drug product specification, manufacturing process, product cost structure etc. thenstatistics China key manufacturers Synthesis Polypeptide Drug capacity production cost priceprofit production value gross margin etc details information, at the same time, statistics thesemanufacturers Synthesis Polypeptide Drug products customers application capacity marketposition company contact information etc company related information, then collect all thesemanufacturers data and listed China Synthesis Polypeptide Drug capacity production capacitymarket share production market share supply demand shortage import export consumption etcdata statistics, and then introduced China Synthesis Polypeptide Drug 2009-2013 capacityproduction price cost profit production value gross margin etc information. And also listedSynthesis Polypeptide Drug upstream raw materials equipments and Sharp Solarnstream clientsalternative products survey analysis and Synthesis Polypeptide Drug marketing channels industrydevelopment trend and proposals. In the end, this report introduced Synthesis Polypeptide Drugnew project SWOT analysis Investment feasibility analysis investment return analysis and alsogive related research conclusions and development trend analysis of China Synthesis PolypeptideDrug industry. In a word, it was a depth research report on China Synthesis Polypeptide Drugindustry. And thanks to the support and assistance from Synthesis Polypeptide Drug industrychain related technical experts and marketing engineers during Research Team survey andinterviews.Get your copy of this report @http://www.reportsnreports.com/reports/185500-2012-market-research-report-on-china-synthesis-polypeptide-drug-industry.html
  • 2. Major points covered in Table of Contents of this report includeTable of ContentsChapter One Synthesis Polypeptide Drug Industry Overview1.1 Synthesis Polypeptide Drug Definition1.2 Synthesis Polypeptide Drug Classification and Application1.3 Synthesis Polypeptide Drug Industry Chain Structure1.4 Synthesis Polypeptide Drug Industry OverviewChapter Two Synthesis Polypeptide Drug International and China Market Analysis2.1 Synthesis Polypeptide Drug Industry International Market Analysis2.1.1 Synthesis Polypeptide Drug International Market Development History2.1.2 Synthesis Polypeptide Drug Product and Technology Developments2.1.3 Synthesis Polypeptide Drug Competitive Landscape Analysis2.1.4 Synthesis Polypeptide Drug International Key Countries Development Status2.1.5 Synthesis Polypeptide Drug International Market Development Trend2.2 Synthesis Polypeptide Drug Industry China Market Analysis2.2.1 Synthesis Polypeptide Drug China Market Development History2.2.2 Synthesis Polypeptide Drug Product and Technology Developments2.2.3 Synthesis Polypeptide Drug Competitive Landscape Analysis2.2.4 Synthesis Polypeptide Drug China Key Regions Development Status2.2.5 Synthesis Polypeptide Drug China Market Development Trend2.3 Synthesis Polypeptide Drug International and China Market Comparison AnalysisChapter Three Synthesis Polypeptide Drug Development Environmental Analysis3.1 Chinas Macroeconomic Environment Analysis3.1.1 China GDP Analysis3.1.2 China CPI Analysis3.2 European Economic Environmental Analysis and Impact3.3 United States Economic Environmental Analysis and Impact3.4 Global Economic Environmental Analysis and ImpactChapter Four Synthesis Polypeptide Drug Development Policy and Plan4.1 China Government Policy and Development Plan4.2 Industry Policy and Standard4.3 Technical Standard4.4 Technology Replacement and R&D Trends4.5 Hotspots and Influence on The IndustryChapter Five Synthesis Polypeptide Drug Manufacturing Process and Cost Structure5.1 Synthesis Polypeptide Drug Product Specifications5.2 Synthesis Polypeptide Drug Manufacturing Process Analysis
  • 3. 5.3 Synthesis Polypeptide Drug Cost Structure AnalysisChapter Six 2009-2013 Synthesis Polypeptide Drug Productions Supply Sales DemandMarket Status and Forecast6.1 2009-2013 Synthesis Polypeptide Drug Capacity Production Overview6.2 2009-2013 Synthesis Polypeptide Drug Production Market Share Analysis6.3 2009-2013 Synthesis Polypeptide Drug Demand Overview6.4 2009-2013 Synthesis Polypeptide Drug Supply Demand and Shortage6.5 2009-2013 Synthesis Polypeptide Drug Import Export Consumption6.6 2009-2013 Synthesis Polypeptide Drug Cost Price Production Value Gross MarginChapter Seven Synthesis Polypeptide Drug Key Manufacturers Analysis7.1 Novartis7.2 Sciclone pharmaceutical Inc7.3 Hybio Pharmaceutical Co., Ltd7.4 Hainan Zhonghe Pharmaceutical Co., Ltd7.5 Beijing Shiqiao Biological Pharmaceutical Co., Ltd7.6 Sichuan Diao Group7.7 Merckserono7.8 Hainan Shuangcheng Pharmaceuticals Co., Ltd7.9 Livzon Pharmaceutical Group Inc7.10 Jiangsu AstrazenecaChapter Eight Up and Sharp Solarn Stream Industry Analysis and Influence8.1 Upstream Raw Materials Price Analysis and Influence8.2 Upstream Equipments Market Analysis and Influence8.3 Sharp Solarnstream Demand Analysis and Influence8.4 Alternative Products Analysis and InfluenceChapter Nine Synthesis Polypeptide Drug Marketing Channels Analysis9.1 Synthesis Polypeptide Drug Marketing Channels Status9.2 Synthesis Polypeptide Drug Marketing Channels Management9.3 Synthesis Polypeptide Drug Marketing Channels Establishment9.4 Synthesis Polypeptide Drug Marketing Channels Development TrendChapter Ten Synthesis Polypeptide Drug Industry Development Trend10.1 2012-2016 Synthesis Polypeptide Drug Development Trend10.2 2012-2016 Market Potential Forecast10.3 2012-2016 R&D Trend10.4 2012-2016 Marketing Channels Change Trend10.5 2012-2016 Competition Pattern Development Trends10.6 2012-2016 Import Export Development Trend
  • 4. Chapter Eleven Synthesis Polypeptide Drug Industry Development Proposals11.1 Macroeconomic Development Countermeasures11.2 New Firms Enter Market Strategy11.3 New Project Investment Proposals11.4 Marketing Channel Strategy Proposals11.5 Competitive Environment Strategy ProposalsChapter Twelve Synthesis Polypeptide Drug New Project Investment Feasibility Analysis12.1 Synthesis Polypeptide Drug Project SWOT Analysis12.2 Synthesis Polypeptide Drug New Project Investment Feasibility AnalysisChapter Thirteen China Synthesis Polypeptide Drug Industry Research ConclusionsList Of Tables and FiguresFigure Synthesis Polypeptide Drug PictureTable Synthesis Polypeptide Drug Classification and Application ListFigure Synthesis Polypeptide Drug Industry Chain StructureTable Synthesis Polypeptide Drug Product Specifications ListFigure Synthesis Polypeptide Drug Manufacturing Process FlowTable 2012 China Synthesis Polypeptide Drug Cost Structure ListTable 2009-2013 China Major Manufacturers Synthesis Polypeptide Drug Capacity and TotalCapacity ListTable 2009-2013 China Major Manufacturers Synthesis Polypeptide Drug Capacity Market ShareListTable 2009-2013 China Major Manufacturers Synthesis Polypeptide Drug Production and TotalProduction ListTable 2009-2013 China Major Manufacturers Synthesis Polypeptide Drug Production MarketShare ListFigure 2009-2013 China Synthesis Polypeptide Drug Capacity Production and Growth RateTable 2009-2013 China Synthesis Polypeptide Drug Capacity Utilization Rate ListFigure 2011 China Major Manufacturers Synthesis Polypeptide Drug Production Market ShareFigure 2012 China Major Manufacturers Synthesis Polypeptide Drug Production Market ShareTable 2009-2013 China Synthesis Polypeptide Drug Demand and Growth RateTable 2009-2013 China Synthesis Polypeptide Drug Supply Demand Shortage ListTable 2009-2013 China Synthesis Polypeptide Drug Production Import Export Consumption ListTable 2009-2013 China Major Manufacturers Synthesis Polypeptide Drug Price ListTable 2009-2013 China Major Manufacturers Synthesis Polypeptide Drug Gross Margin ListTable 2009-2013 China Synthesis Polypeptide Drug Production Price Cost Profit Production ValueGross Margin ListTable Novartis Company Information Table (Products Applications Manufacturing Base Location
  • 5. Capacity Expansion Market Position Contact Information etc 13 Items)Table 2009-2013 Novartis Synthesis Polypeptide Drug Production Price Cost Profit ProductionValue Gross Margin ListFigure 2009-2013 Novartis Synthesis Polypeptide Drug Capacity Production and Growth RateFigure 2009-2013 Novartis Synthesis Polypeptide Drug Production China Market ShareTable Sciclone pharmaceutical Inc Company Information Table (Products ApplicationsManufacturing Base Location Capacity Expansion Market Position Contact Information etc 13Items)Table 2009-2013 Sciclone pharmaceutical Inc Synthesis Polypeptide Drug Production Price CostProfit Production Value Gross Margin ListFigure 2009-2013 Sciclone pharmaceutical Inc Synthesis Polypeptide Drug Capacity Productionand Growth RateFigure 2009-2013 Sciclone pharmaceutical Inc Synthesis Polypeptide Drug Production ChinaMarket ShareTable Hybio Pharmaceutical Co., Ltd Company Information Table (Products ApplicationsManufacturing Base Location Capacity Expansion Market Position Contact Information etc 13Items)Table 2009-2013 Hybio Pharmaceutical Co., Ltd Synthesis Polypeptide Drug Production PriceCost Profit Production Value Gross Margin ListFigure 2009-2013 Hybio Pharmaceutical Co., Ltd Synthesis Polypeptide Drug Capacity Productionand Growth RateFigure 2009-2013 Hybio Pharmaceutical Co., Ltd Synthesis Polypeptide Drug Production ChinaMarket ShareTable Hainan Zhonghe Pharmaceutical Co., Ltd Company Information Table (ProductsApplications Manufacturing Base Location Capacity Expansion Market Position ContactInformation etc 13 Items)Table 2009-2013 Hainan Zhonghe Pharmaceutical Co., Ltd Synthesis Polypeptide DrugProduction Price Cost Profit Production Value Gross Margin ListFigure 2009-2013 Hainan Zhonghe Pharmaceutical Co., Ltd Synthesis Polypeptide Drug CapacityProduction and Growth RateFigure 2009-2013 Hainan Zhonghe Pharmaceutical Co., Ltd Synthesis Polypeptide DrugProduction China Market ShareTable Beijing Shiqiao Biological Pharmaceutical Co., Ltd Company Information Table (ProductsApplications Manufacturing Base Location Capacity Expansion Market Position ContactInformation etc 13 Items)Table 2009-2013 Beijing Shiqiao Biological Pharmaceutical Co., Ltd Synthesis Polypeptide DrugProduction Price Cost Profit Production Value Gross Margin ListFigure 2009-2013 Beijing Shiqiao Biological Pharmaceutical Co., Ltd Synthesis Polypeptide DrugCapacity Production and Growth RateFigure 2009-2013 Beijing Shiqiao Biological Pharmaceutical Co., Ltd Synthesis Polypeptide DrugProduction China Market ShareTable Sichuan Diao Group Company Information Table (Products Applications Manufacturing
  • 6. Base Location Capacity Expansion Market Position Contact Information etc 13 Items)Table 2009-2013 Sichuan Diao Group Synthesis Polypeptide Drug Production Price Cost ProfitProduction Value Gross Margin ListFigure 2009-2013 Sichuan Diao Group Synthesis Polypeptide Drug Capacity Production andGrowth RateFigure 2009-2013 Sichuan Diao Group Synthesis Polypeptide Drug Production China MarketShareTable Merckserono Company Information Table (Products Applications Manufacturing BaseLocation Capacity Expansion Market Position Contact Information etc 13 Items)Table 2009-2013 Merckserono Synthesis Polypeptide Drug Production Price Cost ProfitProduction Value Gross Margin ListFigure 2009-2013 Merckserono Synthesis Polypeptide Drug Capacity Production and Growth RateFigure 2009-2013 Merckserono Synthesis Polypeptide Drug Production China Market ShareTable Hainan Shuangcheng Pharmaceuticals Co., Ltd Company Information Table (ProductsApplications Manufacturing Base Location Capacity Expansion Market Position ContactInformation etc 13 Items)Table 2009-2013 Hainan Shuangcheng Pharmaceuticals Co., Ltd Synthesis Polypeptide DrugProduction Price Cost Profit Production Value Gross Margin ListFigure 2009-2013 Hainan Shuangcheng Pharmaceuticals Co., Ltd Synthesis Polypeptide DrugCapacity Production and Growth RateFigure 2009-2013 Hainan Shuangcheng Pharmaceuticals Co., Ltd Synthesis Polypeptide DrugProduction China Market ShareTable Livzon Pharmaceutical Group Inc Company Information Table (Products ApplicationsManufacturing Base Location Capacity Expansion Market Position Contact Information etc 13Items)Table 2009-2013 Livzon Pharmaceutical Group Inc Synthesis Polypeptide Drug Production PriceCost Profit Production Value Gross Margin ListFigure 2009-2013 Livzon Pharmaceutical Group Inc Synthesis Polypeptide Drug CapacityProduction and Growth RateFigure 2009-2013 Livzon Pharmaceutical Group Inc Synthesis Polypeptide Drug Production ChinaMarket ShareTable Jiangsu Astrazeneca Company Information Table (Products Applications ManufacturingBase Location Capacity Expansion Market Position Contact Information etc 13 Items)Table 2009-2013 Jiangsu Astrazeneca Synthesis Polypeptide Drug Production Price Cost ProfitProduction Value Gross Margin ListFigure 2009-2013 Jiangsu Astrazeneca Synthesis Polypeptide Drug Capacity Production andGrowth RateFigure 2009-2013 Jiangsu Astrazeneca Synthesis Polypeptide Drug Production China MarketShareTable 2012 China Synthesis Polypeptide Drug New Project SWOT Analysis ListTable Synthesis Polypeptide Drug New Project Investment Return and Feasibility Analysis
  • 7. Contact: sales@reportsandreports.com for more information.

×